Now is a critical moment for all involved in caring for cancer patients to engage in this national policy debate; numerous cancer advocacy organizations have already joined the effort to oppose the sequester cuts to oncology drugs.
Michael Diaz, MD
Advertisement
Articles by Michael Diaz, MD
Advertisement
Latest Updated Articles
How the Sequester Cuts Are Harming OncologyPublished: May 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
3
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
